Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Artificial Uterine Contractions in Elective C-Section
NCT03899597Not yet recruiting
- Sponsor
- Institute for the Care of Mother and Child
- Start
- Jan 2024
- Primary completion
- Sep 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in neonatal respiratory distress syndrome (NRDS) (2 arms), sponsored by Institute for the Care of Mother and Child. Primary endpoint: Incidence of neonatal respiratory morbidity at 24 hours. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
neonatal respiratory distress syndrome (NRDS)
Beyond the preview
Go deeper on NCT03899597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899597.